SHE: 002393

Tianjin Lisheng Pharmaceutical Co., Ltd. (SHE: 002393), a Chinese pharmaceutical company, has announced plans to sell its 24.65% stake in the Tianjin subsidiary of Japan-based Mitsubishi Tanabe Pharma Corporation. The assessed value of all shareholder equity, calculated using the income method, is RMB 486 million (USD 67.3 million), marking an…